Longitudinal Metabolomic Profiling of Biogenic Amines in Plasma and CSF, and Their Correlation, Reveals Sex-Specific and Age Changes in TgF344 Alzheimer’s Disease Transgenic and Wildtype Rats

preprint OA: closed CC-BY-NC-ND-4.0

Abstract

Background Alterations in amine metabolism have been implicated Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) and plasma are key biofluids in AD research. CSF is considered to better reflect brain metabolic alterations than plasma, while plasma can be obtained more easily. However, plasma-CSF relationships are unclear. Aim To investigate longitudinal changes of amines in plasma and CSF, and their correlation across the two, in male and female TgF344 AD transgenic versus wildtype (WT) rats. Method LC-MS-based targeted metabolomics was used to analyze 60 and 55 amines in plasma and CSF, respectively, of male and female TgF344-AD and WT rats, at 12, 25, 50 and 85 weeks. Statistical analysis was performed using generalized logistic regressions, Pearson correlations, and differential correlations between groups and matrixes. Results Compared to WT controls, at 12 weeks , TgF344-AD rats showed an increase of 3-methylhistidine, anserine, cysteine, s-methylcysteine, while at 25 weeks , male TgF344-AD rats showed pronounced increases in CSF levels of alpha-aminobutyric acid, asparagine, glycylglycine, glycylproline, histidine, isoleucine, kynurenine, leucine, methionine, methionine sulfone, norepinephrine, phenylalanine, proline, tyrosine, and valine. At 50 weeks , female TgF344-AD rats exhibited reductions in CSF for DL-3-aminoisobutyric acid, gamma-aminobutyric acid, ornithine, and putrescine. Distinct plasma-CSF correlations were found for 1-methylhistidine, 2-aminoadipic acid, putrescine, kynurenine, N6,N6,N6-trimethyl-lysine, DL-3-aminoisobutyric acid, and taurine, particularly in TgF344-AD rats. Conclusions Body fluid, age- and sex-dependent amine alterations in CSF and plasma of TgF344-AD rats compared to WT controls provide important insights into AD disease processes and may aid early diagnosis and therapeutic targeting.
Full text 2,374 characters · extracted from oa-html · 4 sections · click to expand

Abstract

Background Alterations in amine metabolism have been implicated Alzheimer’s disease (AD). Cerebrospinal fluid (CSF) and plasma are key biofluids in AD research. CSF is considered to better reflect brain metabolic alterations than plasma, while plasma can be obtained more easily. However, plasma-CSF relationships are unclear. Aim To investigate longitudinal changes of amines in plasma and CSF, and their correlation across the two, in male and female TgF344 AD transgenic versus wildtype (WT) rats.

Method

LC-MS-based targeted metabolomics was used to analyze 60 and 55 amines in plasma and CSF, respectively, of male and female TgF344-AD and WT rats, at 12, 25, 50 and 85 weeks. Statistical analysis was performed using generalized logistic regressions, Pearson correlations, and differential correlations between groups and matrixes.

Results

Compared to WT controls, at 12 weeks, TgF344-AD rats showed an increase of 3-methylhistidine, anserine, cysteine, s-methylcysteine, while at 25 weeks, male TgF344-AD rats showed pronounced increases in CSF levels of alpha-aminobutyric acid, asparagine, glycylglycine, glycylproline, histidine, isoleucine, kynurenine, leucine, methionine, methionine sulfone, norepinephrine, phenylalanine, proline, tyrosine, and valine. At 50 weeks, female TgF344-AD rats exhibited reductions in CSF for DL-3-aminoisobutyric acid, gamma-aminobutyric acid, ornithine, and putrescine. Distinct plasma-CSF correlations were found for 1-methylhistidine, 2-aminoadipic acid, putrescine, kynurenine, N6,N6,N6-trimethyl-lysine, DL-3-aminoisobutyric acid, and taurine, particularly in TgF344-AD rats.

Conclusions

Body fluid, age- and sex-dependent amine alterations in CSF and plasma of TgF344-AD rats compared to WT controls provide important insights into AD disease processes and may aid early diagnosis and therapeutic targeting. Competing Interest Statement The authors have declared no competing interest. List of abbreviations - AD - Alzheimer’s disease - CSF - Cerebrospinal fluid - WT - Wildtype - GABA - Gamma-aminobutyric acid - BCAAs - Branched-chain amino acids - EDTA - Ethylenediaminetetraacetic acid - BMFL - Biomedical Metabolomics Facility Leiden - MRM - Multiple Reaction Monitoring - FDR - False discovery rate - GLM - Generalized logistic regression models - BBB - Blood-brain barrier - LAT - L-type amino acid transporter

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-NC-ND-4.0